摘要
人类拓扑异构酶IB是一个重要的目标,在癌症的治疗和药物的选择性稳定拓扑异构酶ib-dna共价复合物在几种类型的癌症的临床应用。酪氨酰- DNA磷酸二酯酶1参与DNA的修复解决拓扑异构酶ib-dna共价复合物,对细胞的生存是非常危险的因为它产生不可逆的DNA损伤。由于这两种酶之间的密切的生物学关系,协同抑制剂,称为双抑制剂的发展,是一个重要的挑战,在癌症治疗和计算机辅助药物设计可能有助于识别的最佳化合物。在本综述中,概述了抑制两种酶之一或作为双抑制剂的化合物的概述。此外,对虚拟筛选方法的一般程序,提供了一种描述两种广泛使用的开源程序,即被描述的AutoDock4和AutoDock Vina。最后,一个应用程序的两个项目选定数量的双重抑制剂酪氨酸DNA磷酸二酯酶1和拓扑异构酶IB及其性能进行了简要的讨论。
关键词: AutoDock4,AutoDock Vina,双重抑制剂,indenoisoquinolines,分子对接,拓扑异构酶IB,酪氨酰- DNA磷酸二酯酶,虚拟筛选。
图形摘要
Current Drug Targets
Title:Virtual Screening for the Development of Dual-Inhibitors Targeting Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1
Volume: 18 Issue: 5
关键词: AutoDock4,AutoDock Vina,双重抑制剂,indenoisoquinolines,分子对接,拓扑异构酶IB,酪氨酰- DNA磷酸二酯酶,虚拟筛选。
摘要: Human topoisomerase IB is an important target in cancer therapy and drugs selectively stabilizing the topoisomerase IB-DNA covalent complex are in clinical use for several cancer types. Tyrosyl- DNA phosphodiesterase 1 is involved in the DNA repair resolving the topoisomerase IB-DNA covalent complex that is extremely dangerous for the survival of the cells since it produces an irreversible DNA damage. Given the close biological relationship between these two enzymes, the development of synergistic inhibitors, called dual-inhibitors, is an important challenge in cancer therapy and computer-aided drug design may help in the identification of the best compounds. In this review, an overview of the compounds inhibiting one of the two enzymes or acting as dual inhibitors is provided. Moreover, the general procedures of the virtual screening approach, providing a description of two widely used opensource programs, namely AutoDock4 and AutoDock Vina, are described. Finally, an application of the two programs on a selected number of dual inhibitors for tyrosyl-DNA phosphodiesterase 1 and topoisomerase IB and their performance is briefly discussed.
Export Options
About this article
Cite this article as:
Virtual Screening for the Development of Dual-Inhibitors Targeting Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1, Current Drug Targets 2017; 18 (5) . https://dx.doi.org/10.2174/1389450116666150727114742
DOI https://dx.doi.org/10.2174/1389450116666150727114742 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Comprehensive Review of the Genus Pyrola Herbs in Traditional Uses, Phytochemistry and Pharmacological Activities
Current Topics in Medicinal Chemistry Cancer Targeted Therapy Strategy: The Pathologist’s Perspectives
Current Cancer Drug Targets Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
Recent Patents on Anti-Cancer Drug Discovery Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design Regulation of Leptin Receptor Expression in Human Polarized Caco-2/15 Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Proline-Rich Peptides: Multifunctional Bioactive Molecules as New Potential Therapeutic Drugs
Current Protein & Peptide Science Endoradiotherapy with Peptides - Status and Future Development
Current Medicinal Chemistry Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry Economics of Pharmacogenomics: Rethinking Beyond QALYs?
Current Pharmacogenomics and Personalized Medicine Profiling of Autophagy-Associated microRNAs in the Osteosarcoma Cell Line of U2OS
Anti-Cancer Agents in Medicinal Chemistry Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy Clinical Trials with Oncolytic Adenovirus in China
Current Cancer Drug Targets Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets
Current Cancer Drug Targets Polymers Based on Phenyl Boric Acid in Tumor-Targeted Therapy
Anti-Cancer Agents in Medicinal Chemistry Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene
Current Cancer Therapy Reviews Insulin Delivery Systems for Controlling Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets